Australian regulator initiates legal action against firms for advertising medicinal cannabis

Australia's Therapeutic Goods Administration (TGA) has commenced federal court proceedings against News Corp Australia's News Life Media, AG Therapeutics, Mamamia.com.au, and Straight Up PR for allegedly illegally advertising medicinal cannabis. The TGA alleges the companies breached advertising codes by featuring prohibited representations, testimonials, and endorsements in articles and on websites/social media, despite prior warnings. The regulator is seeking penalties under the Therapeutic Goods Act 1989, which prohibits direct advertising of prescription medicines like medicinal cannabis to the public without approval.

Analysis

News Corp Australia's subsidiary, News Life Media, alongside natural therapies provider AG Therapeutics and media outlet Mamamia.com.au, faces federal court proceedings initiated by Australia's Therapeutic Goods Administration (TGA) over alleged illegal advertising of medicinal cannabis. The TGA contends that articles published by News Life Media and Mamamia breached advertising codes under the Therapeutic Goods Act 1989 by featuring prohibited representations, testimonials, and endorsements, despite multiple prior warnings from the regulator regarding the alleged unlawful advertising. This legislation prohibits direct-to-public advertising of prescription medicines, including medicinal cannabis, without TGA approval. The legal action, which seeks penalties, has generated a "strongly negative" sentiment score of -0.6 and a specific per-ticker sentiment for NWSA of -0.7, reflecting potential reputational damage and financial liabilities. Although the immediate market impact score is moderate at 0.3, the proceedings underscore regulatory compliance risks within News Corp's Australian media operations.

Key Decisions for Investors

• Investors in NWSA should closely monitor the Australian federal court proceedings concerning News Life Media, as potential penalties and reputational harm could arise from these allegations of illegal advertising.
• Given the "strongly negative" sentiment (NWSA specific: -0.7) associated with this legal challenge, an assessment of News Life Media's contribution to News Corp's overall revenue and the potential financial impact of fines is advisable.
• This case highlights heightened regulatory scrutiny over medicinal cannabis advertising in Australia; investors should consider this evolving landscape for media companies and assess if broader compliance risks exist within News Corp's advertising practices.